Senti Biosciences Ownership | Who Owns Senti Biosciences?
Senti Biosciences Ownership Summary
Senti Biosciences is owned by 6.60% institutional investors, 21.01% insiders, and 72.39% retail investors. 8vc gp i is the largest institutional shareholder, holding 5.55% of SNTI shares. ARK Genomic Revolution is the top mutual fund, with 3.76% of its assets in Senti Biosciences shares.
SNTI Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Senti Biosciences | 6.60% | 21.01% | 72.39% |
| Sector | Healthcare Stocks | 49.73% | 8.84% | 41.43% |
| Industry | Biotech Stocks | 47.04% | 8.74% | 44.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| 8vc gp i | 2.54M | 5.55% | $7.00M |
| Intel | 595.66K | 1.30% | $164.40K |
| Geode capital management | 245.59K | 0.54% | $67.80K |
| Two sigma investments, lp | 69.75K | 0.15% | $19.25K |
| Blackrock | 40.05K | 0.09% | $11.05K |
| State street | 39.10K | 0.09% | $10.79K |
| Susquehanna group, llp | 31.40K | 0.07% | $8.67K |
| Triatomic management lp | 15.49K | 0.03% | $4.28K |
| Morgan stanley | 5.40K | 0.01% | $1.49K |
| Bank of america corp /de/ | 820.00 | 0.00% | $227.00 |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| 8vc gp i | 2.54M | 8.67% | $7.00M |
| Triatomic management lp | 15.49K | 0.13% | $4.28K |
| Intel | 595.66K | 0.03% | $164.40K |
| Blackrock | 40.05K | - | $11.05K |
| Susquehanna group, llp | 31.40K | - | $8.67K |
| Ark investment management | - | - | - |
| Comerica bank | - | - | - |
| Bank of america corp /de/ | 820.00 | - | $227.00 |
| Tower research capital llc (trc) | - | - | - |
| Renaissance | - | - | - |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Susquehanna group, llp | 31.40K | - | 31.40K |
| Morgan stanley | 5.40K | - | 3.80K |
| Bank of america corp /de/ | 820.00 | - | 579.00 |
| Blackrock | 40.05K | - | - |
| Geode capital management | 245.59K | - | - |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Nea management company | - | - | -4.43M |
| Ark investment management | - | - | -1.59M |
| Vanguard group | - | - | -707.05K |
| Triatomic management lp | 15.49K | 0.13% | -295.04K |
| Bridgeway capital management | - | - | -145.00K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Susquehanna group, llp | 31.40K | - | 31.40K | $8.67K |
Sold Out
| Holder | Change |
|---|---|
| Toronto dominion bank | -37.00 |
| Comerica bank | -48.00 |
| Wells fargo & company/mn | -202.00 |
| Ubs group | -732.00 |
| Wolverine asset management | -800.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2024 | 2 | -90.00% | 301,803 | -97.10% | 6 | 1.28% | - | -100.00% | 2 | -50.00% |
| Jun 30, 2024 | 20 | -25.93% | 10,389,968 | -5.50% | 22 | 3.75% | 5 | -54.55% | 4 | 33.33% |
| Mar 31, 2024 | 27 | 8.00% | 10,994,171 | -4.07% | 24 | 3.71% | 11 | 10.00% | 3 | 200.00% |
| Dec 31, 2023 | 25 | 4.17% | 11,461,121 | -4.80% | 25 | 3.49% | 10 | 25.00% | 1 | -66.67% |
| Sep 30, 2023 | 24 | -14.29% | 12,038,399 | -1.33% | 27 | 3.55% | 8 | -33.33% | 3 | -25.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| ARK Genomic Revolution | 172.24K | 3.76% | -7.41K |
| ARK Genomic Revolution ETF | 171.89K | 3.75% | 830.00 |
| Vanguard Total Stock Mkt Idx Inv | 58.78K | 1.28% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 38.69K | 0.84% | - |
| Fidelity Extended Market Index | 16.30K | 0.36% | 358.00 |
| Fidelity Total Market Index | 3.81K | 0.08% | - |
| BlackRock Extended Equity Market K | 3.26K | 0.07% | -2.00 |
| Fidelity Series Total Market Index | 3.16K | 0.07% | - |
| Fidelity Nasdaq Composite Index | 2.81K | 0.06% | - |
| NT Ext Equity Mkt Idx Fd - NL | 2.25K | 0.05% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 09, 2024 | BAYER HEALTHCARE LLC | - | Buy | $7.67M |
| Dec 09, 2024 | BAYER HEALTHCARE LLC | - | Buy | - |
| Dec 19, 2013 | Browne Leslie J | President and CEO | Buy | $3.32K |
| May 20, 2013 | Browne Leslie J | President and CEO | Buy | $1.20K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q4 | 2 | - |
| 2024 Q3 | - | - |
| 2024 Q2 | - | - |
| 2024 Q1 | - | - |
| 2023 Q2 | - | - |
SNTI Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools